In another study about the immunomodulatory effects of WBM in prostate cancer, the syngeneic mouse model [mouse prostate cancer cells (TRAMP and Myc-CaP cells) allografted in C57BL/6 or FVB mice, respectively] has been used. This evidence concerns the gene MYC and prostate cancer.